Targeting ANGPTL4 with MAR001: A Promising Approach for Reducing Elevated Triglycerides
Inhibition of ANGPTL4 by MAR001 significantly reduces fasting triglyceride levels in adults with elevated triglycerides, offering a novel therapeutic strategy to manage lipid metabolism and associated cardiovascular risks.








